GLP-2TZ (Tirzepatide Analog) — Lyophilized Powder | For Research Use Only
GLP-2TZ is a lyophilized synthetic dual GIP/GLP-1 receptor agonist peptide analog, supplied as a research-grade compound for in vitro and preclinical laboratory study.
Compound profile
A synthetic 39-amino-acid peptide that acts as an agonist at both GIP and GLP-1 receptors. Used in laboratory research models examining incretin receptor co-activation, cAMP signaling, and metabolic pathway studies.
Specifications
Form: Lyophilized powder (sterile, aseptic fill). Purity: ≥99% by HPLC. Endotoxin testing: LAL method, batch-certified. Stability confirmed by mass spectrometry. COA available per lot.
Storage & handling
Lyophilized: store at -20°C for long-term stability; 2–8°C acceptable short-term. Protect from UV and humidity. Once reconstituted, store at 2–8°C and utilize within 28–30 days. Avoid repeated freeze-thaw cycles.
Regulatory notice
This product is supplied strictly for in vitro and preclinical laboratory research by qualified personnel. It has not been evaluated by the FDA or any equivalent regulatory authority. It is not approved for, nor intended for, human or veterinary use, clinical administration, or dietary supplementation. Not for resale or use outside of a controlled research environment.
Tirzepatide Analog (GLP-2TZ) – Research Peptide
Quality & Specifications
Every batch is synthesized via solid-phase peptide synthesis (SPPS) in controlled lab conditions, lyophilized under aseptic fill, and sealed in borosilicate vials with flip-top crimp caps.
Each lot is verified by:
HPLC — purity confirmed at ≥99%
Mass spectrometry (MS) — molecular identity and weight confirmed
LAL endotoxin testing — batch-certified
Certificate of Analysis — available per lot number on request
Travel case and pen colors are not guaranteed and are based on availability at time of purchase. If a specific color is required, add a note to your order in the cart before checkout, or message us right after placing the order.